<code id='FB8C325229'></code><style id='FB8C325229'></style>
    • <acronym id='FB8C325229'></acronym>
      <center id='FB8C325229'><center id='FB8C325229'><tfoot id='FB8C325229'></tfoot></center><abbr id='FB8C325229'><dir id='FB8C325229'><tfoot id='FB8C325229'></tfoot><noframes id='FB8C325229'>

    • <optgroup id='FB8C325229'><strike id='FB8C325229'><sup id='FB8C325229'></sup></strike><code id='FB8C325229'></code></optgroup>
        1. <b id='FB8C325229'><label id='FB8C325229'><select id='FB8C325229'><dt id='FB8C325229'><span id='FB8C325229'></span></dt></select></label></b><u id='FB8C325229'></u>
          <i id='FB8C325229'><strike id='FB8C325229'><tt id='FB8C325229'><pre id='FB8C325229'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:989
          Illustration of a shopping bag stuffed with medical buildings
          Christine Kao/STAT

          UnitedHealth Group quietly acquired dozens of outpatient facilities in 2023, with a particular focus on surgery centers, according to a STAT review of company financial filings.

          Those acquisitions — nearly all of which the company never announced — build on the network of some 90,000 physicians UnitedHealth Group has amassed in recent years.

          advertisement

          Many of the new centers sit in geographic areas where UnitedHealth is the biggest Medicare Advantage player, based on the latest insurance market share data. That overlap reinforces how UnitedHealth, which is expected to register $400 billion in revenue this year, is looking to funnel more of its insurance members toward providers that it owns. That strategy, known as vertical integration, allows UnitedHealth to capture more profit, and UnitedHealth’s pursuit of it has caught the attention of federal antitrust regulators.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Leukemia patients are helped by Syndax's new type of therapy
          Leukemia patients are helped by Syndax's new type of therapy

          AdobeSANDIEGO—OneofthetoughestsubtypesofacuteleukemiainvolvesageneticalterationintheKMT2Agene.Manyca

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

          ChristineKao/STATTheFoodandDrugAdministration’sapprovalonFridayoftwogenetherapiesforsicklecelldiseas